The Effects of Apremilast Therapy on Deployability in Active Duty US Army Soldiers With Plaque Psoriasis and Psoriatic Arthritis

J Clin Rheumatol. 2021 Apr 1;27(3):127-128. doi: 10.1097/RHU.0000000000001601.

Authors

Andrew D Price¹, Vanya D Wagler², Chase Donaldson³, Patrick J Mastin⁴

Affiliations

¹ From the Department of Internal Medicine, William Beaumont Army Medical Center, El Paso, TX.
² Department of Rheumatology, United Regional Physician Group, Wichita Falls, TX.
³ Department of Intensive Care and Resuscitation, Anesthesiology Institute, Cleveland Clinic Main Campus, Cleveland, OH.
⁴ Department of Rheumatology, William Beaumont Army Medical Center, El Paso, TX.

PMID: 33136692
DOI: 10.1097/RHU.0000000000001601

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Arthritis, Psoriatic* / drug therapy
Humans
Military Personnel*
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Thalidomide / analogs & derivatives

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast